“Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?”, jrenhep, vol. 4, no. 1, pp. 18–21, May 2020, doi: 10.15586/jrenhep.2020.68.